Stelrad Group PLC (SRAD)
London Exchange · UK · prices in GBX · close of 21 Oct 2026
Key indicators
| Last close | GBX 145.00 |
|---|---|
| 52-week range | 108.97 – 163.63 |
| Return, 1 month / 3 months | +0.3% / −7.8% |
| Return, 1 year / 3 years | −6.6% / +79.9% |
| Trend | Uptrend |
| RSI (14) | 53 |
| Volatility (1 year) | 37.6% |
| Worst drawdown (1 year) | -31.4% |
| Average daily value traded | 6.29M GBX |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Stelrad Group PLC makes domestic heating products, chiefly steel panel radiators for homes. The company produces radiators in a range of designs and finishes and sells them under several brand names to plumbing and heating merchants, installers and trade customers. It also supplies related heating accessories. The business is based in the United Kingdom and serves customers in Britain and other European markets, with manufacturing carried out at its own plants.
Stelrad Group PLC trades under the code SRAD on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Stelrad Group PLC (SRAD) trades on the London Exchange in UK. It last closed at GBX 145.00 on 21 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,879 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.6% and over the last three months it fell 7.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.8% | ||
| From 52-week high | -10.4% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.8% | ||
| 6-month return | 13.7% | ||
| 12-month return, skipping the last month | -6.8% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.4% | ||
| Liquidity | 70 · Fair | Moderate trading activity. | |
| Average daily value traded | 6.29M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 34 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.6% |
|---|---|
| 1 month | +0.3% |
| 3 months | −7.8% |
| 6 months | +13.7% |
| 1 year | −6.6% |
| 3 years | +79.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 143.72 / 137.01 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.47 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Oct 2026 | GBP 0.0319 |
| 23 Apr 2026 | GBP 0.0505 |
| 9 Oct 2025 | GBP 0.0304 |
| 24 Apr 2025 | GBP 0.0481 |
| 10 Oct 2024 | GBP 0.0298 |
| 25 Apr 2024 | GBP 0.0472 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.